Compare ERIE & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ERIE | FMS |
|---|---|---|
| Founded | 1925 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Misc Health and Biotechnology Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0B | 13.9B |
| IPO Year | 1995 | 1996 |
| Metric | ERIE | FMS |
|---|---|---|
| Price | $284.63 | $23.63 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $30.00 |
| AVG Volume (30 Days) | 180.3K | ★ 412.0K |
| Earning Date | 10-30-2025 | 02-24-2026 |
| Dividend Yield | 2.08% | ★ 2.40% |
| EPS Growth | ★ 15.90 | 8.62 |
| EPS | ★ 12.39 | 2.86 |
| Revenue | $4,040,325,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $9.98 | $2.13 |
| Revenue Next Year | $5.75 | $2.95 |
| P/E Ratio | $22.75 | ★ $15.87 |
| Revenue Growth | ★ 9.53 | 2.10 |
| 52 Week Low | $273.59 | $22.05 |
| 52 Week High | $456.93 | $30.46 |
| Indicator | ERIE | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 48.51 | 46.72 |
| Support Level | $275.82 | $23.83 |
| Resistance Level | $289.66 | $23.84 |
| Average True Range (ATR) | 5.89 | 0.23 |
| MACD | 0.31 | 0.04 |
| Stochastic Oscillator | 58.76 | 33.10 |
Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.